BBIQ

BBIQ is a potent and selective TLR7 agonist (EC50 = 59.1 nM for human TLR7) that functions as a powerful vaccine adjuvant by enhancing innate immune responses. Its application spans vaccine research and immunology studies, facilitating investigations into TLR7-mediated signaling in both cellular assays and animal models.